258 related articles for article (PubMed ID: 11408221)
1. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
Loutsch JM; Sainz B; Marquart ME; Zheng X; Kesavan P; Higaki S; Hill JM; Tal-Singer R
Antimicrob Agents Chemother; 2001 Jul; 45(7):2044-53. PubMed ID: 11408221
[TBL] [Abstract][Full Text] [Related]
2. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.
Thackray AM; Field HJ
Antimicrob Agents Chemother; 1998 Jul; 42(7):1555-62. PubMed ID: 9660982
[TBL] [Abstract][Full Text] [Related]
3. Effects of antiviral medications on herpetic epithelial keratitis in mice.
Komoto S; Higaki S; Fukuda M; Shimomura Y
Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
Thackray AM; Field HJ
J Infect Dis; 1996 Feb; 173(2):291-9. PubMed ID: 8568288
[TBL] [Abstract][Full Text] [Related]
5. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
LeBlanc RA; Pesnicak L; Godleski M; Straus SE
J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
[TBL] [Abstract][Full Text] [Related]
6. [Battle with herpes for 37 years].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
[TBL] [Abstract][Full Text] [Related]
7. Further evidence from a murine infection model that famciclovir interferes with the establishment of HSV-1 latent infections.
Thackray AM; Field HJ
J Antimicrob Chemother; 2000 Jun; 45(6):825-33. PubMed ID: 10837437
[TBL] [Abstract][Full Text] [Related]
8. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
9. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
[TBL] [Abstract][Full Text] [Related]
10. Early therapy with valaciclovir or famciclovir reduces but does not abrogate herpes simplex virus neuronal latency.
Field HJ; Thackray AM
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):461-70. PubMed ID: 10772727
[TBL] [Abstract][Full Text] [Related]
11. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
Biswas S; Jennens L; Field HJ
Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
[TBL] [Abstract][Full Text] [Related]
12. A thymidine kinase deficient HSV-2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactivates in vivo.
Stroop WG; Banks MC; Qavi H; Chodosh J; Brown SM
J Med Virol; 1994 Jul; 43(3):297-309. PubMed ID: 7931192
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
Field HJ; Tewari D; Sutton D; Thackray AM
Antimicrob Agents Chemother; 1995 May; 39(5):1114-9. PubMed ID: 7625798
[TBL] [Abstract][Full Text] [Related]
14. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
15. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Wagstaff AJ
Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
[TBL] [Abstract][Full Text] [Related]
16. Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
Thackray AM; Field HJ
J Infect Dis; 2000 Apr; 181(4):1517-8. PubMed ID: 10762588
[No Abstract] [Full Text] [Related]
17. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
Valluri S; Fleming TP; Laycock KA; Tarle IS; Goldberg MA; Garcia-Ferrer FJ; Essary LR; Pepose JS
Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
[TBL] [Abstract][Full Text] [Related]
18. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
19. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
